These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 18484327)

  • 1. Prediction of adherence to antiretroviral therapy: can patients' gender play some role? An Italian pilot study.
    Ubbiali A; Donati D; Chiorri C; Bregani V; Cattaneo E; Maffei C; Visintini R
    AIDS Care; 2008 May; 20(5):571-5. PubMed ID: 18484327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of the Multidimensional Health Locus of Control Form C (MHLC-C) for HIV+ subjects: an Italian study.
    Ubbiali A; Donati D; Chiorri C; Bregani V; Cattaneo E; Maffei C; Visintini R
    AIDS Care; 2008 Apr; 20(4):495-502. PubMed ID: 18449829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients].
    Salmon-Céron D; Deleuze J; Coste J; Guerin C; Ginsburg C; Blanche P; Finkielsztejn L; Pecqueux L; Chaput S; Gorin I; Sicard D
    Ann Med Interne (Paris); 2000 Jun; 151(4):297-302. PubMed ID: 10922958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study.
    Hammami N; Nöstlinger C; Hoerée T; Lefèvre P; Jonckheer T; Kolsteren P
    Pediatrics; 2004 Nov; 114(5):e591-7. PubMed ID: 15520091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.
    Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N
    Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-related knowledge and adherence to HAART.
    Weiss L; French T; Finkelstein R; Waters M; Mukherjee R; Agins B
    AIDS Care; 2003 Oct; 15(5):673-9. PubMed ID: 12959818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literacy, self-efficacy, and HIV medication adherence.
    Wolf MS; Davis TC; Osborn CY; Skripkauskas S; Bennett CL; Makoul G
    Patient Educ Couns; 2007 Feb; 65(2):253-60. PubMed ID: 17118617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy.
    Risa KJ; Nepon L; Justis JC; Panwalker A; Berman SM; Cinti S; Wagener MM; Singh N
    Int J STD AIDS; 2002 Oct; 13(10):706-13. PubMed ID: 12396542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.
    Fumaz CR; Muñoz-Moreno JA; Moltó J; Ferrer MJ; López-Blázquez R; Negredo E; Paredes R; Gómez G; Clotet B
    AIDS Care; 2008 Aug; 20(7):796-805. PubMed ID: 18728987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy.
    Luszczynska A; Sarkar Y; Knoll N
    Patient Educ Couns; 2007 Apr; 66(1):37-42. PubMed ID: 17097259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of approaches to enhancing of patient adherence to antivirus therapy in the treatment of human immunodeficiency virus infection].
    Beliaeva VV; Kravchenko AV; Pokrovskiĭ VV
    Ter Arkh; 2003; 75(11):36-8. PubMed ID: 14708439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of antiretroviral adherence.
    Murphy DA; Marelich WD; Hoffman D; Steers WN
    AIDS Care; 2004 May; 16(4):471-84. PubMed ID: 15203415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An examination of HIV/AIDS patients who have excellent adherence to HAART.
    Malcolm SE; Ng JJ; Rosen RK; Stone VE
    AIDS Care; 2003 Apr; 15(2):251-61. PubMed ID: 12856346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.